5 Panel Drug Test, Lovilia, IA
If you need a 5 panel drug test in Lovilia, IA, Accredited Drug Testing Inc has multiple drug testing centers located in Lovilia, IA and throughout the local area. Same day service is available and most testing centers are within minutes of your home or office.
In addition, to our 5 panel drug test, our Lovilia, IA drug testing centers also provide 10 panel, 12 panel, 14 panel and 17 panel drug screenings utilizing urine, hair and oral saliva as testing methods. Alcohol testing including ETG and breath alcohol testing is also available.
The 5 panel drug test is the test which is used by the Department of Transportation (DOT) for all modes and it is the most common drug test used by employers who have a Drug Free Workplace Program.
What is the New DOT 5 panel Drug Test?
On January 1, 2018 the Department of Transportation updated its 5-panel drug test. Employers and safety sensitive individuals should also be aware that DOT Drug Testing at HHS-certified laboratories is a 5-panel drug test procedure. As of January 1, 2018, the ‘Opiates’ category was renamed ‘Opioids’:
- Marijuana (THC)
- Phencyclidine (PCP)
Under ‘Opioids’, previously ‘Opiates’, DOT testing will continue to include confirmatory testing, when appropriate, for Codeine, Morphine, and 6-AM (heroin).
We added initial and confirmatory testing for the semi-synthetic opioids Hydrocodone, Hydromorphone, Oxycodone, and Oxymorphone to this Opioids group. Some brand names for the semi-synthetic opioids include OxyContin®, Percodan®, Percocet®, Vicodin®, Lortab®, Norco®, Dilaudid®, Exalgo®.
Under Amphetamines, DOT testing includes confirmatory testing, when appropriate, for Amphetamine, Methamphetamine, MDMA, and MDA. To this Amphetamines group, we added initial testing for MDA and removed testing for MDEA.
Since January 1st, we have required confirmation testing for 14 drugs under a 5-panel test. Broken out, here is what DOT drug testing looks like:
- Marijuana (THC)
- 6-AM (heroin)
Both a standard 5 panel drug test or a 5 panel + Expanded Opiates drug test is available when scheduling. A 5 panel drug test can be conducted utilizing urine or hair follicles.
The 5 panel drug test Lovilia, IA service is commonly used for court, school programs, internships, employment or by employers who utilize a 5 panel drug test as part of a drug free workplace. The 5 panel drug test is becoming a more common drug test for individuals and employers wishing to screen for prescription drugs in addition to common street drugs.
The 5 panel drug test Lovilia, IA service can also have additional screens added including expanded opiates, which will cover 7 additional opiate drug classifications.
A standard 5 panel drug test Lovilia, IA service screens for the following drugs
- Phencyclidine (PCP)
- Roughly 21 to 29 percent of patients prescribed opioids for chronic pain misuse them.
- Between 8 and 12 percent develop an opioid use disorder.
- An estimated 4 to 6 percent who misuse prescription opioids transition to heroin.
- About 80 percent of people who use heroin first misused prescription opioids.
- Opioid overdoses increased 30 percent from July 2016 through September 2017 in 52 areas in 45 states.
- The Midwestern region saw opioid overdoses increase 70 percent from July 2016 through September 2017.
- Opioid overdoses in large cities increase by 54 percent in 16 states.
A 5-panel drug test Lovilia, IA service with expanded opiates screens for these additional drugs,
Accredited Drug Testing Inc offers a 5 panel drug test Lovilia, IA service and 5 panel + expanded opiates drug test which is analyzed by a SAMHSA Certified Laboratory and reviewed by a Medical Review Officer (MRO). Negative results are typically available within 24-48hrs.
Accredited Drug Testing Inc also offers a 5 panel drug test Lovilia, IA service with rapid results which provide negative results the same day. Non-negative results will be sent to the laboratory for confirmation testing.
What is an instant drug test?
An instant drug test is a test administered at a drug testing facility in which the specimen is tested by the technician using a dipstick or other type of immediate analysis process. Instant tests are very sensitive and should not be used for court ordered or any disciplinary action against an employee. The results of an instant test in which the test is non-negative should always be sent to a SAMHSA certified laboratory for confirmation testing. An example of the sensitivity of an instant test would be a person taking a completely legal diet pill as part of a weight loss program, but the instant test reports a positive result for amphetamines when a laboratory analysis may not do so. Any time an instant test has a positive result for any drug screened in the specimen should be sent to a certified laboratory for confirmation testing and verification by a Medical Review Officer.
The Opioid Overdose Crisis
Every day, more than 130 people in the United States die after overdosing on opioids. The misuse of and addiction to opioids—including prescription pain relievers, heroin, and synthetic opioids such as fentanyl—is a serious national crisis that affects public health as well as social and economic welfare. The Centers for Disease Control and Prevention estimates that the total "economic burden" of prescription opioid misuse alone in the United States is $78.5 billion a year, including the costs of healthcare, lost productivity, addiction treatment, and criminal justice involvement
In the late 1990s, pharmaceutical companies reassured the medical community that patients would not become addicted to prescription opioid pain relievers, and healthcare providers began to prescribe them at greater rates. This subsequently led to widespread diversion and misuse of these medications before it became clear that these medications could indeed be highly addictive.3,4 Opioid overdose rates began to increase. In 2017, more than 47,000 Americans died as a result of an opioid overdose, including prescription opioids, heroin, and illicitly manufactured fentanyl, a powerful synthetic opioid.1That same year, an estimated 1.7 million people in the United States suffered from substance use disorders related to prescription opioid pain relievers, and 652,000 suffered from a heroin use disorder (not mutually exclusive)
Accredited Drug Testing Inc is pleased to provide a 5 panel drug test Lovilia, IA service. To schedule a 5 panel drug test Lovilia, IA, Call (800)221-4291 or online.
6580 165TH ST 8.4 miles
ALBIA, IA 52531
107 N 3RD ST 14.0 miles
EDDYVILLE, IA 52553
1002 S LINCOLN ST 16.1 miles
KNOXVILLE, IA 50138
1229 C AVE E 18.1 miles
OSKALOOSA, IA 52577
410 N 12TH ST STE 300 18.2 miles
OSKALOOSA, IA 52577
604 LIBERTY ST STE 227 18.6 miles
PELLA, IA 50219
404 JEFFERSON ST 19.1 miles
PELLA, IA 50219
For information on drug testing in the private and public sector – CLICK HERE
For more information on drug and alcohol addiction – CLICK HERE
Local Area Info: Lovilia, Iowa
As of the census of 2010, there were 538 people, 207 households, and 149 families residing in the city. The population density was 1,076.0 inhabitants per square mile (415.4/km2). There were 228 housing units at an average density of 456.0 per square mile (176.1/km2). The racial makeup of the city was 99.4% White, 0.2% African American, 0.2% Native American, and 0.2% from two or more races. Hispanic or Latino of any race were 0.7% of the population.
There were 207 households of which 36.7% had children under the age of 18 living with them, 54.6% were married couples living together, 12.1% had a female householder with no husband present, 5.3% had a male householder with no wife present, and 28.0% were non-families. 26.6% of all households were made up of individuals and 8.7% had someone living alone who was 65 years of age or older. The average household size was 2.60 and the average family size was 3.11.
The median age in the city was 34 years. 29.4% of residents were under the age of 18; 7.9% were between the ages of 18 and 24; 24.8% were from 25 to 44; 23.4% were from 45 to 64; and 14.3% were 65 years of age or older. The gender makeup of the city was 49.1% male and 50.9% female.